Fractalkine Gene Receptor Polymorphism in Patients With Multiple Sclerosis

REFERENCES

• Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Stewart GJ. An investigation of polymorphisms in the 4q1 3.3–21.1 CXC chemokine gene cluster for association with multiple sclerosis. Mult Scler. 2006;12(6):710–22.
   PubMedGoogle Scholar
• Greve B, Simonenko R, Illes Z, Peterfalvi A, Hamdi N, Mycko MP, Selmaj KW, Rozsa C, Rajczy K, Bauer P, Berger K, Weissert R. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland. Mult. Scler. 2008;14(2):153–58
   Web of Science ®Google Scholar
• Kamali-Sarvestani E, Nikseresht AR, Aliparasti MR, Vessal M. IL-8(-251A/T) and CXCR2(+1208 C/T gene polymorphisms and risk of multiple sclerosis in Iranian patients. Neurosci Lett. 2006;404(1–2):159–62.
   PubMed Web of Science ®Google Scholar
• Broux B, Pannemans K, Zhang X, Markovic-Plese S, Broekmans T, Eijnde BO, Van Wijmeersch B, Somers V, Geusens P, van der Pol S, van Horssen J, Stinissen P, Hellings N. CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients. Autoimmun. 2012;38(1):10–9. Epub 2011, Nov 26
   Web of Science ®Google Scholar
• Stojković L, Djurić T, Stanković A, Dinčić E, Stančić O, Veljković N, Alavantić D, Zivković M. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis. J Neuroimmunol. 2012;245(1–2):87–92. Epub 2012, Jan 18.
   PubMed Web of Science ®Google Scholar
• Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 2006;9(7):917–24.
   PubMed Web of Science ®Google Scholar
• Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patient. J Clin Invest. 1999;103(6):807–15
   PubMed Web of Science ®Google Scholar
• Qu W, Hashimoto SI, Shimada A, Nakatani Y, Ichikawa K, Saito TL, Ogoshi K, Matsushima K, Suzuk Y, Sugano S, Takeda H, Morishita S. Genome-wide genetic variations are highly correlated with proximal DNA methylation patterns. Genome Res. 2012;22(8):1419–25.
   PubMed Web of Science ®Google Scholar
• Klotz L, Gold R, Hemmer B, Korn T, Zipp F, Hohlfeld R, Kieseier BC, Wiendl H. Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria. Nervenarzt. 2011;82(10):1302–9.
   PubMed Web of Science ®Google Scholar
• Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C. Association of common polymorphism in the fractalkine receptor(CX3CR1) with obesity. Obesity (Silver Spring). 2011;19(1):222–7
   PubMed Web of Science ®Google Scholar
• Kimouli M, Miyakis S, Georgakopoulos P, Neofytou E, Achimastos AD, Spandidos DA. Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis. J Atheroscler Thromb. 2009;16(5):604–10
   PubMed Web of Science ®Google Scholar
• Debette S, Bevan S, Dartigues JF, Sitzer M, Lorenz M, Ducimetière P, Amouyel P, Markus HS. Fractalkine receptor/ligand genetic variants and carotid intima-media thickness. Stroke. 2009;40(6):2212–4.
   PubMed Web of Science ®Google Scholar
• Dimberg J, Dienus O, Lalfgren S, Hugander A, Wagsater D. Polymorphism of fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. Int J Colorectal Dis. 2007;22(10):1195–2000.
   Web of Science ®Google Scholar
• Amanatidou V, Sourvinos G, Apostolakis S, Tsilimigaki A, Spandidos DA. T 280 M variations of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 2006;25(5):410–4.
   PubMed Web of Science ®Google Scholar
• Apostolakis S, Amanatidou V, Papadakis EG, Spendidos DA. Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis. Atherosclerosis. 2009;207(1):8–15.
   PubMed Web of Science ®Google Scholar
• Hattori H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N. T280 M and V2491 polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. Neurosci Lett. 2005;374(2):132–5.
   PubMed Web of Science ®Google Scholar
• Lundmark F, Salter H, Hillert J. An association study of two functional promotor polymorphism in the myeloperoxidase gene in multipl sclerosis. Mult. Scler. 2007;13(6):687–700.
   Google Scholar
• Kamali-Sarvestani E, Nikseresht AR, Aflaki E, Sarvari J, Gharesi-Fard B. TNFalpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis. Acta Neurol Scand. 2007;115(3):161–6
   PubMed Web of Science ®Google Scholar
• Martinez A, de las Heras V, Mas Fontao A, Bartolome M, de la Concha EG, Urcelay E, Arroyo R. An IFNG polymorphism is associated with interferon-beta response in Spanish MS patients. J Neuroimmunol. 2006;173(1–2):196–9.
   PubMed Web of Science ®Google Scholar
• Kikuchi S, Miyagishi R, Fukazawa T, Yabe I. TNF related apoptosis induced ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunl. 2005;167(12):170–4.
   PubMedGoogle Scholar
• Gade-Andovolu R, Comings DE, MacMurray J, Vuthoori RK, Tourtellotte WW, Nagra RM, Cone LA. RANTES: a genetic risk marker for multiple sclerosis. Mult Scler. 2004;10(5):536–9
   PubMed Web of Science ®Google Scholar
• Djurik T, Zivkovic M, Stankovic A, Dincic E, Raicevic R, Alavantic D. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia. J Neurol Sci. 2008;267(1–2):62–5.
   PubMed Web of Science ®Google Scholar